Matches in Wikidata for { <http://www.wikidata.org/entity/Q71657509> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q71657509 description "article scientifique publié en 1983" @default.
- Q71657509 description "artículu científicu espublizáu en febreru de 1983" @default.
- Q71657509 description "im Februar 1983 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71657509 description "scientific article published on 01 February 1983" @default.
- Q71657509 description "wetenschappelijk artikel" @default.
- Q71657509 description "наукова стаття, опублікована в лютому 1983" @default.
- Q71657509 name "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 name "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 name "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 type Item @default.
- Q71657509 label "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 label "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 label "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 prefLabel "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 prefLabel "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 prefLabel "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 P1433 Q71657509-1FD5BEAA-EA47-44F8-8550-D3F3A0A6D8F5 @default.
- Q71657509 P1476 Q71657509-14B65D1D-5F93-4A5C-BEC7-5590139DF964 @default.
- Q71657509 P2093 Q71657509-5E4EFB71-B631-4B05-89BC-36680EB4EF2F @default.
- Q71657509 P2093 Q71657509-BA24C1EE-0D55-4206-B1AA-A0E61C35F987 @default.
- Q71657509 P2093 Q71657509-D51C0658-3227-43C7-9DFC-639DD812B393 @default.
- Q71657509 P2860 Q71657509-148DFBAD-3B88-4522-BCB9-A1E66D5AA20C @default.
- Q71657509 P2860 Q71657509-15FF49A9-BAD8-4782-83F5-EA5F3E1F1E1C @default.
- Q71657509 P2860 Q71657509-4B478A5D-FAAA-497A-82C6-973A31180EE1 @default.
- Q71657509 P2860 Q71657509-5987E057-2C89-4B74-8A9A-F9506436EF54 @default.
- Q71657509 P2860 Q71657509-63857027-77EB-46DD-86C7-2E357B56AAFA @default.
- Q71657509 P2860 Q71657509-72A13B2B-0CD5-4323-9201-A60B972582F1 @default.
- Q71657509 P2860 Q71657509-79579DB1-FBD3-43AF-A403-F6B56B33F32B @default.
- Q71657509 P2860 Q71657509-91DDA677-90B3-48C3-B503-A11812E0AF65 @default.
- Q71657509 P2860 Q71657509-B189695C-1688-4982-8033-B5EF87534158 @default.
- Q71657509 P2860 Q71657509-B407C29A-11FE-4ADD-AA58-CA99DCD948D4 @default.
- Q71657509 P2860 Q71657509-C34EC99E-FD4A-4482-9B26-3DAFDDB6848F @default.
- Q71657509 P2860 Q71657509-D2431570-3E5E-467B-B59D-16B4985C697B @default.
- Q71657509 P2860 Q71657509-D36DC170-FF9C-413F-B404-FB15E412BD7C @default.
- Q71657509 P2860 Q71657509-EB195528-A6E7-489F-8EA8-3D436CC0FEDC @default.
- Q71657509 P2860 Q71657509-EC942325-53D4-4308-B6CE-63416E8FBED8 @default.
- Q71657509 P2860 Q71657509-ED7E1050-5946-4A19-98CB-9F055D5E338F @default.
- Q71657509 P2860 Q71657509-F3567356-BE38-4EDF-9BE7-4FEEC9F1CEAD @default.
- Q71657509 P304 Q71657509-9C809A18-F613-4AF2-BAC9-8456D46CE555 @default.
- Q71657509 P31 Q71657509-AF49341E-6DFE-402F-AF4A-228ADFBA83E1 @default.
- Q71657509 P356 Q71657509-FB5FB587-5EF7-4230-8126-1811DC118FDA @default.
- Q71657509 P407 Q71657509-0BD44CB5-8470-4352-A254-DD1FA8B931CF @default.
- Q71657509 P433 Q71657509-C3254015-9718-4829-AED9-840FEC39FE90 @default.
- Q71657509 P478 Q71657509-88A4AC67-1EBB-4AA9-8054-2196507AF8EC @default.
- Q71657509 P577 Q71657509-D978DD84-0814-4A7A-9E7A-96D12AF11120 @default.
- Q71657509 P698 Q71657509-9E7929C5-36F3-470A-A650-B31E490AAFFD @default.
- Q71657509 P356 S0002-9149(83)80081-2 @default.
- Q71657509 P698 6823861 @default.
- Q71657509 P1433 Q2208417 @default.
- Q71657509 P1476 "Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol" @default.
- Q71657509 P2093 "J Mehta" @default.
- Q71657509 P2093 "L Roy" @default.
- Q71657509 P2093 "P Mehta" @default.
- Q71657509 P2860 Q28244623 @default.
- Q71657509 P2860 Q28330215 @default.
- Q71657509 P2860 Q39130630 @default.
- Q71657509 P2860 Q39250033 @default.
- Q71657509 P2860 Q39462769 @default.
- Q71657509 P2860 Q39991773 @default.
- Q71657509 P2860 Q40938301 @default.
- Q71657509 P2860 Q41038213 @default.
- Q71657509 P2860 Q41067461 @default.
- Q71657509 P2860 Q54539649 @default.
- Q71657509 P2860 Q67294490 @default.
- Q71657509 P2860 Q67769711 @default.
- Q71657509 P2860 Q67874720 @default.
- Q71657509 P2860 Q72134548 @default.
- Q71657509 P2860 Q72507690 @default.
- Q71657509 P2860 Q72676967 @default.
- Q71657509 P2860 Q72769159 @default.
- Q71657509 P304 "464-467" @default.
- Q71657509 P31 Q13442814 @default.
- Q71657509 P356 "10.1016/S0002-9149(83)80081-2" @default.
- Q71657509 P407 Q1860 @default.
- Q71657509 P433 "3" @default.
- Q71657509 P478 "51" @default.
- Q71657509 P577 "1983-02-01T00:00:00Z" @default.
- Q71657509 P698 "6823861" @default.